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Abstract
Purpose To differentiate proxy renal cystic lesions contain-
ing protein, blood, iodine contrast or saline solutions using
dual-energy CT (DECT) equipped with a new tin filter
technology (TFT).
Materials and methods 70 proxies (saline, protein, blood
and contrast agent) were placed in unenhanced and
contrast-enhanced kidney phantoms. DECT was performed
at 80/140 kV with and without tin filtering. Two readers
measured the CT attenuation values in all proxies twice. An
80/140 kV ratio was calculated.
Results All intra- and interobserver agreements were excellent
(r=0.93–0.97; p<0.001). All CT attenuation values were
significantly higher in the enhanced than in the unenhanced
setting (p<0.05; average increase, 12.5±3.6HU), while the
ratios remained similar (each, p>0.05). The CT attenuation of
protein, blood and contrast agent solution differed signifi-
cantly with tin filtering (p<0.01–0.05). Significant differ-
ences were found between the ratios of protein and blood
compared to contrast medium solution (each, p<0.05) and
between the ratios of protein and blood in both phantoms
with tin filtering (each, p<0.05).
Conclusion DECT allows discrimination between a proxy
renal lesion containing contrast agent and lesions contain-
ing protein and blood through their different attenuation at
80 kV and 140 kV. Further discrimination between protein
and blood containing proxies is possible when using a tin
filter.
Keywords Dual-energy CT. DECT. Renal cysts .
Kidney lesions . Tin filter
Introduction
Cystic renal lesions are estimated to be present in 20–
40% of the population and represent frequent, most of
the times incidental findings in abdominal computed
tomography (CT) examinations [1]. Alongside the cyst’s
diameter, wall thickness, presence of septa and contrast
enhancing components, the measurement of the mean CT
attenuation value (in Hounsfield Units, HU) of the cysts’
content on unenhanced CT images as well as the
assessment of its attenuation pattern after the administra-
tion of intravenous contrast media are supporting the
radiologists to classify cystic renal lesions [2]. Cysts
surrounded by thin, smooth walls and mean CT attenu-
ation values between 0 and 20 HU are considered simple
benign cysts if they do not enhance after the application
of contrast agents [2–4]. These cysts are classified
category I by Bosniak [1]. Homogeneous cysts with mean
CT attenuation values between 40 and 90 HU on
unenhanced CT images are considered hyperattenuating
cysts if they are also enclosed by thin, smooth walls and
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do not enhance after contrast agent administration [3].
Cysts containing blood (i.e. haemorrhagic cysts) or protein
(i.e. proteinaceous cysts) also represent as hyperattenuating
cystic renal lesions on unenhanced CTexaminations [5, 6]. In
general, cystic renal lesions measuring between 20 and
40 HU may be considered proteinaceous cysts. In case
of attenuation values of 40–50 HU the lesions content
may be of haemorrhagic origin [7]. These homoge-
neously hyperattenuating, non-enhancing cystic renal
lesions are considered benign and classified category II
by Bosniak [1]. Therefore follow-up CT examinations are
not required.
On contrast-enhanced single-energy CT images, hae-
morrhagic or proteinaceous contents as well as contrast
enhancement may be responsible for an increase in
attenuation value of a cystic renal lesion’s content.
However, unless additional unenhanced CT is performed,
contrast agent uptake cannot be determined or ruled-out
reliably. Furthermore, the differentiation between hae-
morrhagic and proteinaceous cystic renal lesions is
currently not possible with standard, single-energy CT
acquisition techniques [5, 7]. However, this differentiation
might be of interest in order to differentiate renal cell
carcinomas from haemorrhagic or inflammatory renal
cysts.
The purpose of this study was to assess the performance
of dual-energy CT (DECT) equipped with a new tin filter
technology to differentiate renal cyst proxies containing
protein, blood, iodinated contrast agent or saline solution in
an experimental phantom study setup.
Materials and methods
Kidney phantom
A hollow acrylic elliptic sphere (120×65×65 mm)
served as a kidney phantom. In a first benchmark model,
the phantom was filled with minced beef mixed with
distilled water to simulate unenhanced renal parenchyma
(unenhanced kidney phantom). In a second benchmark
model, the phantom was filled with minced beef mixed
with iodinated contrast agent (Ultravist, 300 mg iodine/mL,
Bayer Schering Pharma, Berlin, Germany) to a mean CT
attenuation of 250 HU as measured at 120 kV single-
energy CT to simulate contrast-enhanced renal parenchy-
ma in the nephrographic phase (contrast-enhanced kidney
phantom).
Cystic renal lesion proxies
Seventy spherical proxies were manufactured from rubber
gloves and randomly filled with either sterile saline, fresh
human blood, bovine serum albumine or iodinated contrast
agent solutions:
& 10 proxies filled with sterile saline solution resulting in a
mean CT attenuation value of 0 HU simulating simple
renal cysts;
& 20 proxies filledwith iodinated contrast medium (Ultravist,
300 mg iodine/mL, Bayer Schering Pharma, Berlin,
Germany) titrated with distilled water to concentrations of
0.9 mg (n=10) and 1.8 mg (n=10) iodine/ml and mean
CT attenuation values of 20 and 40 HU simulating renal
mass lesions with different degrees of attenuation;
& 20 proxies filled with bovine serum albumine (Cohn
Fraction V, ≥96% purified lyophilized powder, Sigma
Aldrich Co., St. Louis MO, USA) titrated with distilled
water to mean CT attenuation values of 20 and 40 HU
simulating proteinaceous renal cysts with different
degrees of attenuation;
& 20 proxies filled with fresh human blood titrated with
distilled water to mean CT attenuation values of 20 and
40 HU simulating complicated haemorrhagic renal cysts
with different degrees of attenuation.
The CT attenuation of all titrated solutions was deter-
mined by mean CT attenuation value measurements upon
single-energy CT images of each lesion proxy in the kidney
phantom using the following CT acquisition parameters:
collimation 64×0.6 mm, slice acquisition 128×0.6 mm by
means of a z-flying focal spot, tube voltage 120 kV, tube
current-time product 200 mAs, pitch 0.35, and rotation time
0.33 s. Images of this acquisition were reconstructed to a
slice thickness of 1.0 mm at a reconstruction increment of
0.7 mm using a standard soft tissue convolution kernel
(B30f).
Experimental setup
Each ten cystic renal lesion proxies titrated to different CT
attenuation values (i.e. 20 HU and 40 HU) were randomly
placed inside the kidney phantom ensuring that each proxy
was completely surrounded by minced beef and was neither
in contact with another proxy nor with the wall of the
phantom. A radiologist not involved in data analysis noted
the position of each renal proxy and its content. The
assembled kidney phantom was submerged in a 28-cm tank
filled with distilled water to simulate surrounding body
attenuation. The water tank was then examined using a
second-generation 128-slice dual-source CT system
(SOMATOM Definition Flash, Siemens Healthcare, For-
chheim, Germany) operated using two different protocols:
Protocol A: Tube voltage pair of 140 kV and 80 kV with
tube current time products of 56 mAs and
308 mAs, respectively, no tin filtering.
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Protocol B: Tube voltage pair of 140 kV and 80 kV with
tube current time products of 140 mAs and
333 mAs and tin filtering of the 140 kV tube.
For DECT, the tube currents were adjusted to yield
constancy in CT volume dose index of 9.0 mGy for both
protocols. The CT acquisition parameters were: collimation,
32×0.6 mm, slice acquisition, 64×0.6 mm by means of a z-
flying focal spot, pitch, 0.35, and gantry rotation time, 0.5 s. All
image data was reconstructed to a slice thickness of 1.0mm at a
reconstruction increment of 0.7 mm using a soft tissue
convolution kernel specifically designed for DECT (D30).
All images of the DECT acquisitions of the unenhanced
and contrast-enhanced phantom were reformatted display-
ing only a single proxy at a time for both protocols (i.e.
with and without tin-filtering) and energy spectra (i.e.
80 kV and 140 kV). All text annotations were removed
from all images by a radiologist not involved in data
analysis.
CT data analysis
A radiologist not involved in further data analysis measured
the size of each lesion proxy using an electronic calliper
tool. The anonymised dual-energy images were displayed
in random order to two radiologists experienced in
genitourinary imaging. Both observers (Reader 1, R1,
4 years of genitourinary cross-sectional image interpretation
experience; and Reader 2, R2, 3 years of experience) were
blinded to each other and independently performed a
quantitative analysis of the CT attenuation values by
placing a region of interest inside each proxy. Each
observer repeated the measurement within a time interval
of 2 weeks in a second data analysis session. The standard
deviation of the mean CT attenuation value in each lesion
was noted and considered to define image noise.
Statistical analysis
All statistical analysis was performed using commercially
available software (SPSS, release 17.0, Chicago, IL, USA).
A p-level < 0.05 was considered to indicate statistical
significance.
Categorical variables were expressed as frequencies
and percentages. Numerical variables were expressed as
means±standard deviations. Kruskal Wallis analysis was
performed to test for differences in lesion proxy size
among the different groups. Inter- and intra-observer
agreements concerning measurement of CT attenuation
values within the lesion proxies were assessed using
Pearson’s analysis. The ratio of the mean CT attenuation
values between 80 kV and 140 kV (i.e. 80/140 ratio; DE-
Ratio) was calculated for each setting. CT attenuation
values and DE-ratios were statistically compared using
the Wilcoxon paired-sample test.
Results
Cystic renal lesion proxies’ characteristics
The average size of all lesion proxies (i.e. 20±3 mm; range,
14–28 mm) was similar (p=0.29) for different concentrations
(i.e. 20 HU and 40 HU) and contents.
Intraobserver and interobserver agreements
Intra- (R1, r=0.97; p<0.001; R2, r=0.95; p<0.001) and
interobserver (r=0.93; p<0.001) agreements for all CT
attenuation value measurements were excellent. Thus, the
average of CT attenuation value measurements of both
readers and both image analysis sessions were used for
further statistical analysis.
Quantitative measurements of the proxies’ contents
A summary of the quantitative analysis of the CT attenuation
values in both protocols (i.e. with and without tin filtering) and
kidney phantoms (i.e. contrast-enhanced and unenhanced) is
provided in Tables 1 and 2.
Comparison of results between both phantoms
In the contrast-enhanced phantom, all CT attenuation values
were significantly higher than in the unenhanced phantom
(average increase, 12.5±3.6 HU; p<0.05) in both energy
spectra (i.e. 80 kVand 140 kV) with and without tin filtering.
There was no significant difference in DE-ratios of the
protein-, blood-, and contrast-containing proxies between the
two phantoms (each, p>0.05).
Unenhanced kidney phantom
Comparing protein-, blood-, and contrast-containing proxies,
the CT attenuation values were significantly different at
140 kV (each, p<0.01) and 80 kV (each, p<0.05), with
and without tin filtering (Fig. 1).
There was a significant difference of the CT attenu-
ation values of protein-, blood-, and contrast-containing
proxies between 80 kV and 140 kV with tin filtering
(each, p<0.05) and for contrast-containing proxies with-
out tin filtering (p<0.01), while no significant difference
was found for protein- (p=0.74) and blood-containing
proxies (p=0.38) without tin filtering between 80 kV and
140 kV. With the use of a tin filter, the DE-ratios were
significantly different for protein-containing proxies (p<
Eur Radiol (2011) 21:385–392 387
0.01, Table 1) when compared to the non-tin filtered
acquisition.
Contrast-enhanced kidney phantom
The CT attenuation values of protein-, blood-, and contrast-
containing proxies were significantly different at 80 kV
(each, p<0.05) and 140 kV (each, p<0.01, Fig. 1), with and
without tin filtering.
There was a significant difference of the CT attenuation
values between 80 kV and 140 kV for protein-, blood-, and
contrast-containing proxies with tin filtering (each, p<0.01)
as well as for contrast-containing proxies without tin
filtering (p<0.01). No significant difference was found for
protein- (p=0.21) and blood-containing proxies (p=0.08)
between 80 kV and 140 kV. With and without tin filtering,
the DE-ratios were significantly different for protein-
containing proxies (p<0.01, Table 2).
Image noise
The image noise was significantly lower in the tin-filtered
acquisitions (16±1 HU) when compared to the non-tin-
filtered acquisitions (18±1 HU; p<0.05).
Discrimination of protein, blood and contrast agent
Without the application of tin filtering, the DE-ratios for
protein- and blood-containing proxies were significantly
different from the DE-ratios of contrast containing proxies
in the unenhanced (Fig. 2a) and contrast-enhanced phantom
(each, p<0.05; Fig. 2b). There was no significant difference
in the DE-ratios between protein- and blood-containing
proxies in the unenhanced (p=0.79; Fig. 2a) and contrast-
enhanced kidney phantom (p=0.29; Fig. 2b).
With the application of tin filtering, the DE-ratios for
protein- and blood-containing proxies were significantly
Table 1 Quantitative analysis of the proxies’ CT attenuation values in the unenhanced kidney phantom
aNCT 120kV Protocol A—tin filter OFF Protocol B—tin filter ON p values
c
aNCT 80kV
aNCT 140kV Ratio 80/140
aNCT 80kV
bSN aNCT 140kV SN Ratio 80/140 SN
Saline 0 2.5±1.7 2.5±1.1 1.1±1.1 2.1±2.1 2.5±1.8 1.2±0.8 0.72
Protein 20 16.9±1.4 16.8±1.5 1.0±0.1 14.3±2.4 18.4±1.3 0.8±0.1 <0.01
40 39.0±1.4 38.8±1.7 1.0±0.1 34.9±2.5 43.7±2.0 0.8±0.1 <0.01
Blood 20 20.0±1.1 18.3±2.8 1.1±0.2 21.7±1.9 17.5±1.2 1.2±0.1 0.12
40 35.9±2.0 33.5±2.1 1.1±0.1 37.7±3.3 33.7±2.3 1.1±0.1 0.38
Contrast medium 20 25.2±1.4 12.0±1.0 2.1±0.2 20.9±1.4 10.7±0.8 2.0±0.2 0.48
40 46.5±1.5 24.1±2.0 2.0±0.1 42.3±2.2 18.8±1.3 2.2±0.3 0.06
a CT attenuation value measurement in Hounsfield units (HU)
b SN = tin filter
c p values are derived from statistical comparison of the different ratios between CT attenuation values measured at 80 kV and 140 kV between protocol A
and protocol B (Wilcoxon paired sample test)
Table 2 Quantitative analysis of the proxies’ CT attenuation values in the contrast enhanced kidney phantom
aNCT 120kV Protocol A—Tin Filter OFF Protocol B—Tin Filter ON p values
c
aNCT 80kV
aNCT 140kV Ratio 80/140
aNCT 80kV
bSN aNCT 140kV SN Ratio 80/140 SN
Saline 0 12.2±2.8 10.8±2.7 1.1±0.2 13.1±2.9 10.8±3.8 1.2±0.5 0.53
Protein 20 32.9±6.4 32.9±5.9 1.0±0.1 22.4±2.6 31.3±5.0 0.7±0.1 <0.01
40 48.8±2.8 51.0±2.0 1.0±0.1 41.9±3.0 50.2±5.9 0.8±0.1 <0.01
Blood 20 33.7±4.8 28.9±3.3 1.2±0.2 34.4±2.8 25.4±3.1 1.4±0.1 0.07
40 51.0±4.8 44.2±4.0 1.2±0.1 49.3±3.3 37.9±3.6 1.3±0.1 0.23
Contrast medium 20 45.9±6.0 23.2±2.0 2.0±0.3 36.9±3.9 18.4±3.0 2.0±0.2 0.47
40 59.5±2.6 31.9±2.2 1.9±0.2 57.7±2.6 27.5±1.9 2.1±0.2 0.19
a CT attenuation value measurement in Hounsfield units (HU)
b SN = tin filter
c p values are derived from statistical comparison of the different ratios between CT attenuation values measured at 80 kV and 140 kV between protocol A
and protocol B (Wilcoxon paired sample test)
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different from the DE-ratios of contrast containing proxies in
the unenhanced (Fig. 2c) and contrast-enhanced kidney
phantom (each, p<0.05; Fig. 2d). The DE-ratios between
protein- and blood-containing proxies were significantly
different in the unenhanced (p<0.05; Fig. 2c) and contrast-
enhanced kidney phantom (p<0.05; Fig. 2d).
Discussion
The purpose of this study was to discriminate cystic
renal lesion proxies with different contents using DECT
with a new tin filtering technology. Our results have
shown, that a differentiation between contrast material
containing cystic renal lesion proxies and protein- or
blood-containing cystic renal lesion proxies is feasible
using 80/140 kV ratios calculated from DECT data.
Further on we were able to discriminate protein- from
blood containing cystic renal lesion proxies by using an
additional tin filter.
In the early 1970s, DECT had been introduced for material
decomposition making use of attenuation characteristics of
different materials at two different X-ray energy spectra [8].
The recent introduction of dual-source CT (DSCT) systems
has re-enlivened DECT for various clinical indications [9–
17], owing to the simultaneous data acquisition of two X-ray
tube-detector systems at two different X-ray spectra.
Common applications of DECT include the reconstruc-
tion of virtual unenhanced images to spare the (true)
unenhanced CT acquisition and therefore reduce the total
radiation dose [9–12], the detailed use of material decom-
position techniques to characterise urinary stones of
different compositions [9, 13–16], the separation of xenon
from air [18], or blood from air [19, 20].
Recently, the second generation of DSCT systems—
equipped with a new tin filter technology for increased X-ray
energy spectra separation [17]—was introduced. These tin
filters, mounted on the 140 kV tube, have been suggested,
but not proven to further improve the differentiation of
material sharing overlapping attenuation values at single-
Fig. 1 Imaging examples of
renal cyst proxies containing
blood, contrast media,
saline solution, and protein at
single-energy CT (120 kV) and
dual-energy CT with and
without tin filtering in
the unenhanced and contrast-
enhanced kidney phantom. Note
the difference in attenuation
of the cysts and the contrast-
enhanced minced beef at
the various X-ray energy spectra
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energy CT examinations. Very recently an improved differ-
entiation of urinary calculi has been reported using tin filtered
dual-energy CT [21, 22]. Additionally, Leschka et al. were
able to differentiate renal cysts from contrast-enhancing renal
mass lesions by applying the tin filter technology to dual-
energy CT [23] and Graser et al. have reported an added
value of tin-filtered DECT when determining the dignity of
renal lesions [24].
The classification of renal cysts using abdominal CT
primarily relies on their attenuation behaviour on unen-
Fig. 2 Dual-energy ratio of the CT attenuation value at 80 kV/140 kV
for protein, blood, and contrast-containing lesion proxies without tin
filtering in the unenhanced (a) and contrast-enhanced kidney phantom
(b); and with tin filtering in the unenhanced (c) and contrast-enhanced
kidney phantom (d). With and without tin filtering, the 80/140 kV
ratios of protein and blood-containing proxies were significantly
different from that of the contrast-containing proxies in the unen-
hanced and contrast-enhanced kidney phantom (each, p<0.05).
Without tin filtering (a,b), there was no significant difference in the
80/140 kV ratios between protein and blood-containing lesions, while
the 80/140 kV ratios were significantly different with the application
of the tin filter (c,d)
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hanced images and on their enhancement pattern after the
administration of intravenous iodinated contrast agent.
However, most cystic renal lesions are discovered inciden-
tally on contrast-enhanced abdominal CT examinations
performed for non-renal indications [1] and in case of
equivocal findings regarding their attenuation on contrast-
enhanced CT studies, patients may need to be recalled to
undergo a second, unenhanced abdominal CT, a procedure
causing increased costs and radiation exposure to the
patient. Moreover, the assessment of enhancement of cystic
renal lesions may be prone to errors by erroneously
assuming a “true” enhancement in the presence of the—so
called—pseudoenhancement, which refers to an artificial
increase in attenuation of a simple renal cyst following
contrast agent application, and is most problematic for
small cysts at high levels of renal parenchymal enhance-
ment [8, 9]. This issue is further complicated by the fact
that certain renal cell carcinomas may enhance in a rather
weak and homogeneous manner [25]. Pseudoenhancement
thus may lead to mischaracterization of a small renal cyst as
a neoplasm eventually leading to unnecessary interventions.
We found higher CT attenuation values in the contrast-
enhanced kidney phantom compared to the unenhanced
phantom, due to this pseudoenhancement. Interestingly, the
dual-energy ratios for blood-, protein-, and contrast-containing
cystic renal lesion proxies were similar in both phantoms.
The principle of DECT bases on the varying attenuations
of different materials at two different X-ray energy spectra
[9–11, 13–15, 17]. In a recent study, the ability of DECT
(without tin filter technology) to discriminate renal cysts
from iodine containing renal masses was shown, with a
sensitivity of 97% and specificity of 83% [26]. Our study
confirms and extends those results by demonstrating the
feasibility of DECT to differentiate proteinaceous or
haemorrhagic from contrast containing cystic renal lesion
proxies by means of their different attenuation behaviour at
140 kV and 80 kV. We found that the DE-ratios of protein-
or blood-containing proxies differ significantly from the
DE-ratios of contrast-containing proxies. Consequently,
DECT allows for the discrimination of protein- or blood-
containing cystic renal lesion proxies from contrast-
containing proxies. Therefore, additional unenhanced CT
need not be performed. Our study also demonstrates that a
further discrimination between proteinaceous and haemor-
rhagic proxies is feasible when applying a tin filter. Without
this tin filter, a substantial overlap in the CT attenuation
values measured at 140 kV and 80 kV was found between
protein- and blood-containing proxies. This may be
explained by the suboptimal separation of X-ray energy
spectra without the use of a tin filter which is particularly
important for material with only minor differences in X-ray
absorption [14]. The tin filter reduces overlap in X-ray
energy spectra by increasing the mean photon energy of the
140 kV-tube and, therefore, improves both material differ-
entiation and decomposition [17]. As a matter of fact, we
found different DE-ratios between the attenuation values
measured at 140 kV and 80 kV for proteinaceous cysts with
or without the application of the tin filter. Consequently, a
significantly different DE-ratio between protein- and blood-
containing proxies was found in the protocol applying the
tin filter allowing for the discrimination of these contents.
Albeit the phantom used in our study was designed to
simulate optimal conditions comparable to in-vivo abdom-
inal CT, we have to acknowledge some limitations. This is
a phantom study, and therefore the performance of DECT
for discriminating protein, blood, and lesions containing
contrast agent needs to be validated in further clinical
studies. Furthermore, we assumed albumin to be the main
component in proteinaceous renal cysts. The real content of
proteinaceous cysts might vary from patient to patient and
may depend on a possible underlying pathology. Therefore,
the DE-ratios in clinical abdominal CT might differ from
our results, and a larger overlap of the CT attenuation
values measured at 140 kV and 80 kV between protein and
blood content might limit the discrimination of proteina-
ceous and haemorrhagic cysts in clinical practice. However,
we have chosen albumin because it is highly available in
purified condition, and, therefore, easy to handle in experi-
mental settings. Another limitation may be the size of the
kidney phantom. With a diameter of 28 cm, a comparison to
human bodies is not possible. The attenuation values of cystic
renal lesions may vary in vivo. Another option for dual-energy
CT in vivo is the use of a 140 kV/100 kV protocol, which may
be helpful especially in obese patients.
Conclusion
In conclusion, DECT is able to discriminate proteinaceous
or haemorrhagic cystic renal lesion proxies from cystic
renal lesion proxies containing contrast agent through their
different attenuation behaviour at 140 kV and 80 kV.
Applying the tin filter technology to DECT allows for a
further discrimination of protein and blood content within
the cystic renal lesion proxies.
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